CPI-2081

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCPI-2081
Drug Alias Namecysteine protease inhibitor (National Chemical Laboratory)CPI-2081
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCathepsin B inhibitorsMetastasis inhibitors
TargetsCathepsin B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Chemical Laboratory
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A